SCHEMBL3986308

SCHEMBL3986308

CC(C)(C)N1CCN(c2ccc([N+](=O)[O-])c(N)c2)CC1

nearest known ligand 0.72

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.72
SIRT6 Q8N6T7 4/20 0.72
LMNA P02545 2/20 0.69
RECQL P46063 1/20 0.64
HPGD P15428 2/20 0.49
KMT2A Q03164 2/20 0.48
MEN1 O00255 1/20 0.48
ALDH1A1 P00352 5/20 0.48
CYP1A2 P05177 3/20 0.48
CYP2C19 P33261 3/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
CYP2C9 P11712 2/20 0.46
MAPK1 P28482 2/20 0.45
TSHR P16473 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
CYP3A4 P08684 1/20 0.45
HTR7 P34969 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16654817 0.89 MAPT (0.57) MAPTSIRT6LMNARECQLHPGD
SCHEMBL77148 0.84 SIRT6 (1.00) MAPTSIRT6LMNARECQLALDH1A1
SCHEMBL11296150 0.83 MAPT (0.50) MAPTSIRT6LMNAHPGDKMT2A
SCHEMBL11371732 0.83 SIRT6 (0.53) MAPTSIRT6LMNAHPGDKMT2A
SCHEMBL3109069 0.82 LMNA (1.00) MAPTSIRT6LMNARECQLHPGD
SCHEMBL30059159 0.82 LMNA (1.00) MAPTSIRT6LMNARECQLHPGD
SCHEMBL25877527 0.82 LMNA (0.94) MAPTSIRT6LMNARECQLHPGD
SCHEMBL27890392 0.81 MAPT (0.62) MAPTSIRT6LMNARECQLHPGD
SCHEMBL11305986 0.81 SIRT6 (0.74) MAPTSIRT6LMNAHPGDKMT2A
SCHEMBL3381562 0.81 LMNA (0.97) MAPTSIRT6LMNARECQLHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2951153-A1 SELECTIVE HDAC3 INHIBITORS Acetylon Pharmaceuticals, Inc. (US) 2015-12-09 EP disclosed
WO-2014121062-A1 SELECTIVE HDAC3 INHIBITORS ACETYLON PHARMACEUTICALS, INC. (US) 2014-08-07 WO disclosed
EP-2061768-A2 IMIDAZOLE-4,5-DICARBOXAMIDE DERIVATIVES AS JAK-2 MODULATORS Exelixis, Inc. (US) 2009-05-27 EP disclosed
WO-2008042282-A2 IMIDAZOLE-4, 5-DICARBOXAMIDE DERIVATIVES AS JAK-2 MODULATORS EXELIXIS, INC. (US) 2008-04-10 WO disclosed